Objective. We aimed to evaluate the presenting features and treatment outcome of prostate cancer in men age
Purpose: We defined the yield and nature of prostate cancer in the setting of population based, rand...
A single early prostate-specific antigen (PSA) level has been correlated with a higher likelihood of...
textabstractBackground: Prostate cancer screening depends on a careful balance of benefits, in terms...
Prostate cancer is a potential men’s health problem. The prevalence of prostate cancer continues to ...
Do not routinely screen all men over the age of 50 for prostate cancer with the prostate-specific an...
Introduction:Recommendations for prostate-specific antigen-based screening for prostate cancer are p...
Background: It is common to start with PSA (prostate-specific antigen)-testing at the age of 50. If ...
Background: Current prostate cancer screening guidelines conflict with respect to the age at which t...
Objectives. To evaluate the diagnostic findings and treatment options chosen in men aged 70 years an...
ImportanceDespite ongoing controversies surrounding prostate-specific antigen (PSA) screening, many ...
Background: Prostate cancer is a risk for men aged 40+ even if it is rarely seen among men under the...
Prostate cancer (CaP) in younger men (age ≤50 years) appears to present differently compared with ol...
Objectives. To evaluate the diagnostic findings and treatment options chosen in men aged 70 years an...
Background: Prostate cancer screening depends on a careful balance of benefits, in terms of reduced ...
Background: Prostate cancer screening depends on a careful balance of benefits, in terms of reduced ...
Purpose: We defined the yield and nature of prostate cancer in the setting of population based, rand...
A single early prostate-specific antigen (PSA) level has been correlated with a higher likelihood of...
textabstractBackground: Prostate cancer screening depends on a careful balance of benefits, in terms...
Prostate cancer is a potential men’s health problem. The prevalence of prostate cancer continues to ...
Do not routinely screen all men over the age of 50 for prostate cancer with the prostate-specific an...
Introduction:Recommendations for prostate-specific antigen-based screening for prostate cancer are p...
Background: It is common to start with PSA (prostate-specific antigen)-testing at the age of 50. If ...
Background: Current prostate cancer screening guidelines conflict with respect to the age at which t...
Objectives. To evaluate the diagnostic findings and treatment options chosen in men aged 70 years an...
ImportanceDespite ongoing controversies surrounding prostate-specific antigen (PSA) screening, many ...
Background: Prostate cancer is a risk for men aged 40+ even if it is rarely seen among men under the...
Prostate cancer (CaP) in younger men (age ≤50 years) appears to present differently compared with ol...
Objectives. To evaluate the diagnostic findings and treatment options chosen in men aged 70 years an...
Background: Prostate cancer screening depends on a careful balance of benefits, in terms of reduced ...
Background: Prostate cancer screening depends on a careful balance of benefits, in terms of reduced ...
Purpose: We defined the yield and nature of prostate cancer in the setting of population based, rand...
A single early prostate-specific antigen (PSA) level has been correlated with a higher likelihood of...
textabstractBackground: Prostate cancer screening depends on a careful balance of benefits, in terms...
DOI
Add to ORKG